Skip to main content
TipRanks
Go Ultimate75% OFF

Sempreon (M1I) AI Stock Analysis

0 Followers
CH:M1I

Sempreon

(BX Swiss:M1I)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Ingredient Solutions DemandStrong specialty protein demand and a fully booked production schedule indicate customer traction in higher-value ingredients. Sustained utilization and repeat demand can support revenue visibility, improve the segment’s strategic importance, and help offset weakness in more cyclical distilling activities.
Negative Factors
Sharp Profitability DeteriorationThe move from sustained profitability to a substantially larger trailing loss signals that current earnings power is impaired. Persistent operating losses can weaken the equity base, constrain investment capacity, and make a durable recovery dependent on successful margin and demand improvement.

Sempreon Business Overview & Revenue Model

Company Description

Sempreon, Inc., formerly MGP Ingredients, Inc., is a provider of branded and distilled spirits and food ingredient solutions, founded in 1941 and headquartered in Atchison, Kansas. It operates in three segments. Branded Spirits (formerly Luxco) devel...

Sempreon Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|Next Earnings Date:Feb 25, 2027
Earnings Call SentimentNeutral

The call presented a mixed picture. Management highlighted better-than-expected adjusted EBITDA and EPS, debt reduction, strong cash generation, cost savings, brand momentum, expanding white goods and emerging-customer sales, and improving Ingredient Solutions reliability. These positives were offset by substantial year-over-year declines in consolidated results, Distilling Solutions, brown goods, margins, and net income, along with ongoing distributor-transition effects, plant-related costs, industry oversupply, customer inventory reductions, and higher interest expense. The balance of meaningful operational progress and significant current-period declines supports a neutral overall assessment.

Positive Updates

Adjusted EBITDA and EPS Beat Expectations
Third-quarter sales were $117.9 million, down versus the prior year and in line with expectations, while adjusted EBITDA of $21.5 million and adjusted basic EPS of $0.39 both declined year over year but came in ahead of expectations.

Negative Updates

Broad-Based Consolidated Financial Declines
Third-quarter consolidated sales declined 10% year over year to $117.9 million. Gross profit declined 18% to $40.5 million, consolidated gross margin fell approximately 350 basis points to 34.3%, net income declined 55% to $6.9 million, reported EPS fell to $0.32 from $0.71, adjusted EPS declined 54% to $0.39, and adjusted EBITDA decreased 33%.

Company Guidance

The company reaffirmed full-year 2026 net sales of between $480 million and $500 million, Adjusted EBITDA of $90 million to $98 million, adjusted basic earnings per share of between $1.50 and $1.80, weighted average basic shares outstanding of approximately 21.4 million, operating cash flow of $50 million to $55 million and free cash flow of $30 million to $35 million, both excluding the impact of the Penelope earn out payment; it expects Branded Spirits sales to decline mid single digits with Premium Plus up low single digits, Distilling Solutions sales to be down approximately 35% year over year and gross profit to be down approximately 40%, and Ingredient Solutions sales to be in the $140 million-$150 million range with gross margins in the high single to low double digit range, while Branded Spirits A&P is expected to be approximately 12% to 13% of Branded Spirits sales, adjusted SG&A approximately 16% of sales, the effective tax rate approximately 23% for the full year, full-year net whiskey put away in the range $30 million to $80 million, CapEx approximately $20 million, and full year interest expenses approximately $12 million; the fourth quarter is expected to be stronger than the third, with fourth quarter interest expense sequentially higher than Q3.

Sempreon Risk Analysis

Sempreon disclosed 35 risk factors in its most recent earnings report. Sempreon reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Sempreon Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

CH:M1I against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
BF.ABF.A66Neutral$14.30B20.0117.80%2.91%-0.18%-13.00%
SAMSAM64Neutral$2.23B-32.23-9.81%―-3.71%-180.44%
CCUCCU61Neutral$1.98B18.647.00%2.64%5.55%-19.14%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
WESTWEST54Neutral$888.66M-15.86-21.74%―16.29%42.55%

* General Sector Average

Performance Comparison

0%100%200%300%SAMBF.ACCUWESTAGCCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:M1I and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SAMBoston Beer Company220.1619.209.55%
BF.ABrown Forman Inc A31.745.3320.16%
CCUCompania Cervecerias Unidas10.83-2.06-16.01%
WESTWestrock Coffee Company8.884.96126.53%
AGCCAgencia Comercial Spirits Ltd. Class A14.478.93161.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.